Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf InhibitorsAlexandra E. Gould, Katherine Galvin, Roushan Afroze et al.|Journal of Medicinal Chemistry|2011Cited by 33
Abstract A081: Resistance Mechanisms to Monotherapy RAS(ON) Multi-Selective Inhibitor Daraxonrasib (RMC-6236) in RAS Mutant PDAC Inform Therapeutic Combination StrategiesIda Aronchik, Mallika Singh, Sumit Kar et al.|Molecular Cancer Therapeutics|2025Cited by 1